79249944 - HYA

Information

  • Trademark
  • 79249944
  • Serial Number
    79249944
  • Registration Number
    5929291
  • Filing Date
    September 20, 2018
    7 years ago
  • Registration Date
    December 10, 2019
    6 years ago
  • Transaction Date
    December 10, 2024
    a year ago
  • Status Date
    December 10, 2019
    6 years ago
  • Published for Opposition Date
    September 24, 2019
    6 years ago
  • Location Date
    December 10, 2019
    6 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    VAGHANI, MAYUR
  • Attorney Docket Number
    TM19-0220
    Law Office Assigned Location Code
    O30
  • Owners
Mark Drawing Code
5
Mark Identification
HYA
Case File Statements
  • DM0000: The mark consists of the stylized word "HYA" written vertically.
  • GS0051: Pharmaceutical preparations other than for agricultural purposes for the treatment and prevention of metabolic and endocrine diseases, namely, diabetes, diabetic complication, hyperlipidemia, hyperuricemia, gout, lifestyle related disease, nutritional disorders, impaired glucose tolerance, metabolic syndrome, obesity and lipid disorder, cardiovascular, urological and reproductive diseases, namely, hypertension, hyperglycemia, ischemic heart disease, hyperinsulinemia, arteriosclerosis, myocardial infarction, angina pectoris, aneurysm, chronic kidney disease, renal calculi, kidney disease, pyelonephritis, nephritis, urethritis, cystitis, hypercholesterolemia and high triglyceridemia, respiratory diseases, namely, bronchitis, pulmonary emphysema and lung inflammation, digestive and oral diseases, namely, abnormality of the intestinal flora, abdominal distension, peptic ulcer, intestinal disease, inflammatory disorder, irritable bowel syndrome, gastric ulcer, inflammatory bowel disease, Crohn's disease, diverticulitis, liver cirrhosis, fatty liver, diarrhea, constipation, loose stool disease, hepatic inflammation, non-alcoholic steatohepatitis, viral hepatitis, alcoholic hepatitis, dental disease, periodontal diseases, stomatitis, xerostomia and cyst, immune, inflammatory and allergic diseases, namely, immune related diseases and abnormalities, type I, II, III, IV and V allergy, pollinosis, atopic dermatitis, psoriasis, autoimmune disease and connective tissue disease, bone and articular diseases, namely, rheumatism, osteoporosis and articular inflammation, pathogenic microbial and malignant neoplastic diseases, namely, infection, cancer and malignant tumor, mental and nervous system diseases, namely, mental disorder, dementia, Alzheimer's disease, bipolar disorder, depression, anorexia, insomnia, cerebral apoplexy, cerebral infarction, autism, neuroinflammation, overwork related disease and nerve inflammation related diseases and cancers resulting from chronic inflammation, and sensory system and skin diseases, namely, ophthalmic disease, ocular inflammation, otorhinolaryngology disease and skin inflammation; pharmaceutical preparations in the nature of medicines for dental purposes; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceutical for medicine doses; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages; antiseptic liquid bandages; breast-nursing pads; dental composite, impression and porcelain materials; dental materials, namely, dental porcelain materials, materials for making dental impressions and composite materials for dental and dental technical purposes; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; beverages for babies, namely, human breast milk, powdered milk, isotonic beverages for babies; food for babies; dietary supplements for animals
  • GS0161: Paper and cardboard; printed matter, namely, paper signs, books, manuals, curricula, newsletters, information cards and brochures in the field of health
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0351: Advertising and publicity services
  • TR0010: The wording "HYA" has no meaning in a foreign language.
  • GS0011: Chemicals, namely, chemical additives for use in the manufacture of food, pharmaceuticals, cosmetics and animal feed; perfluorinated chemical compounds prepared synthetically for use in the manufacture of cosmetics and pharmaceuticals; food preserving chemicals; chemical preparations for preserving foodstuffs; chemical products for the fresh-keeping and preserving of food; chemical products for stabilizing foodstuffs; chemicals for industrial purposes; chemicals for use in the manufacture of a wide variety of goods; glue and adhesives for industrial purposes; plant growth regulating preparations; fertilizers; higher fatty acids for industrial purposes; chemical compositions for developing, printing and enlarging photographs; unprocessed plastics
Case File Event Statements
  • 1/24/2019 - 7 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 1/25/2019 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/25/2019 - 7 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/25/2019 - 7 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/26/2019 - 7 years ago
    5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 1/29/2019 - 7 years ago
    6 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 2/8/2019 - 7 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 2/8/2019 - 7 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 3/2/2019 - 7 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 7/17/2019 - 6 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/17/2019 - 6 years ago
    11 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 7/22/2019 - 6 years ago
    12 - ASSIGNED TO LIE Type: ALIE
  • 7/25/2019 - 6 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/25/2019 - 6 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/19/2019 - 6 years ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/4/2019 - 6 years ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/18/2019 - 6 years ago
    17 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 9/18/2019 - 6 years ago
    18 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 9/24/2019 - 6 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/24/2019 - 6 years ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/5/2019 - 6 years ago
    21 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 12/10/2019 - 6 years ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/10/2020 - 6 years ago
    23 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 3/24/2020 - 6 years ago
    24 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 3/24/2020 - 6 years ago
    25 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 4/10/2020 - 6 years ago
    26 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 2/12/2021 - 5 years ago
    27 - CHANGE OF OWNER RECEIVED FROM IB Type: CHLD
  • 12/10/2024 - a year ago
    28 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3